AbCellera Biologics Price Target Announced at $13.00/Share by Goldman Sachs
Ratings actions from Benzinga
Related stories
Republican Senator Kevin Cramer Calls On Nvidia CEO To Resign — Politico
L impact | NEWS | Nov 11, 2026, 02:58 AM UTC
Republican US Senator Kevin Cramer from Senate Banking Committee urges Nvidia CEO to resign: Politico
L impact | NEWS | Nov 11, 2026, 02:54 AM UTC
Bonds Update: Japan 10Y Bond Yield Gains by 8 bps
Government bonds yields are higher on Wednesday. Top gainers are Japan 10Y (7.59bps), South Korea 10Y (6.80bps) and New Zealand 10Y (5.80bps).
L impact | NEWS | Nov 11, 2026, 02:30 AM UTC
Asia FX Updates: South Korean Won Rises by 0.34%
Top currency gainers are South Korean Won (0.34%) and Australian Dollar (0.26%). Biggest losers are Indonesian Rupiah (-0.27%) and Japanese Yen (-0.11%). Meanwhile Chinese Yuan was
L impact | NEWS | Nov 11, 2026, 02:15 AM UTC
Alphabet Mandates HSBC And JP Morgan As Joint Global Coordinators For Potential Debut HKD And SGD Bond Offering, Term Sheet Shows
L impact | NEWS | Nov 11, 2026, 01:55 AM UTC
Nvidia-Backed Cohere in A ‘Fight’ To Secure AI Computing Power
L impact | NEWS | Nov 11, 2026, 01:54 AM UTC